Among obese patients, however, plasma levels of clusterin were found to be increased as well as directly related to obesity-related metabolic disease complications, among which were insulin resistance, dyslipidemia, and hepatic steatosis [24]. This evidence concerns the gene CLU and Hepatic steatosis.